Article info

Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer

Authors

  1. Correspondence to Professor Andrea Ardizzoni; andrea.ardizzoni{at}aosp.bo.it
View Full Text

Citation

Ardizzoni A, Azevedo S, Rubio-Viqueira B, et al
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer

Publication history

  • Accepted October 12, 2022
  • First published November 30, 2022.
Online issue publication 
October 09, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.